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ABSTRACT: Mycotoxin mitigation is of major interest as ingestion of mycotoxins results in poor animal health, decreased
productivity, as well as substantial economic losses. A feed additive (FA) consisting of a combination of bacteria (Eubacterium
BBSH797) and enzyme (fumonisin esterase FumD) was tested in pigs for its ability to neutralize the eﬀects of mono- and co-
contaminated diets with deoxynivalenol (DON) and fumonisins (FB) on hematology, biochemistry, tissue morphology, and
immune response. Forty-eight animals, allocated into eight groups, received one of eight diets for 35 days: a control diet, a diet
contaminated with either DON (3 mg/kg) or FB (6 mg/kg), or both toxins, and the same four diets with FA. Inclusion of FA
restored the circulating number of neutrophils of piglets fed the FB and DON + FB diets. Similarly, FA counteracted the minor
changes observed on plasma concentrations of albumin and creatinine. In lung, the lesions induced by the ingestion of FB in
mono- and co-contaminated diets were no longer observed after addition of FA in these diets. Lesions recorded in the liver of
pigs fed either of the contaminated diets with FA were partly reduced, and the increased hepatocyte proliferation was totally
neutralized when FA was present in the co-contaminated diet. After 35 days of exposure, the development of the vaccinal
response was signiﬁcantly improved in animals fed diets supplemented with FA, as shown by results of lymphocyte proliferation,
cytokine expression in spleen, and the production of speciﬁc Ig. Similarly, in jejunum of animals fed diets with FA, occurrence of
lesions and upregulation of pro-inﬂammatory cytokines were much less obvious. The ameliorative eﬀects provided by FA suggest
that this approach would be suitable in the control of DON and FB that commonly co-occur in feed.
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■ INTRODUCTION
Mycotoxins are structurally diverse low-molecular-weight
metabolites produced by fungi. As secondary metabolites, they
are not essential to fungi growth butmay contaminate animal and
human feeds at all stages of the food chain. Their global
occurrence is considered to be a major risk factor aﬀecting both
human and animal health, and additionally causing substantial
economic losses.1
Among mycotoxins, deoxynivalenol (DON) and fumonisins
(FB) are both produced by Fusarium species (mostly F.
graminearum and F. verticillioides, respectively). The major
problem associated with animal feed contaminated with
mycotoxins is not acute disease episodes, but rather the ingestion
of low level of toxins which may cause an array of metabolic,
physiologic, and immunologic disturbances.1,2 For instance,
ingestion of realistic doses of DON has been reported to alter
functions of the gut epithelium, such as permeability, mucosal
immunity, and nutrient utilization.3−6 At low doses, FB interfere
with mechanisms of resistance and immune function, predispos-
ing animals to pulmonary infections and increasing intestinal
pathogen colonization.7−9 Besides, both DON and FB have been
reported in separate studies to impair the development of
vaccinal response.10,11
As evidenced by recent surveys, animals are usually exposed to
more than one mycotoxin.12−14 The eﬀects resulting from
mycotoxin co-contamination are poorly documented, but
toxicity of combinations of mycotoxins cannot be predicted
from the individual toxicities of the toxins.15 With regard to the
eﬀects of DON and FB in association, a few studies demonstrated
that these two toxins act in an additive manner on the induction
of hepatic lesions, on the modulation of intestinal functions, or
on the reduced eﬃcacy of vaccination.16−19
Good feed management practices on the farm are major goals
in controlling mycotoxicosis in livestock and poultry.20,21
However, despite substantial eﬀorts, prevention of mycotoxin
formation in stored feeds is not always feasible. Methods based
on the inclusion of feed additive to inhibit the intestinal
absorption of mycotoxins have gained popularity over the past
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decade.22 Given the frequent occurrence of multitoxin
contaminated feed, the feed additive must be able to target
diﬀerent types of mycotoxins at the same time. Due to the diverse
structures and properties of these metabolites, this issue remains
critical in the development of control strategies. In line with that,
adsorbents such as clays (HSCAS, bentonite), yeast, or bacteria
were demonstrated to work very eﬀectively with regard to
preventing aﬂatoxicosis.23−25 By contrast, the adsorption and the
subsequent elimination of other mycotoxins, particularly
trichothecenes (DON, T-2 toxin) and fumonisins, are much
less obvious.23,25 New strategies for mycotoxins other than
aﬂatoxin must be therefore considered. To this end, a promising
approach would be the use of microorganisms or enzymes able to
convert mycotoxins into much less toxic metabolites. Recently,
some publications showed the ability of some microorganisms to
degrade zearalenone, trichothecenes, ochratoxin A, and
fumonisins.26−29 Among them, the bacterium designated
BBSH 797 isolated from rumen content was the ﬁrst to be
developed as a feed additive microorganism for detoxiﬁcation of
mycotoxins. This bacterial strain is able to biotransform the
epoxide group of trichothecenes into a diene. DON is
enzymatically reduced by a de-epoxydase of Eubacterium BBSH
797 to the nontoxic metabolite de-epoxy-deoxynivalenol (DOM-
1).27,28 Very recently, we showed that hydrolyzed fumonisin,
initially obtained from a treatment of fumonisin with the
fumonisin esterase FumD, was nontoxic when orally given to
piglets.30 This enzyme possesses the ability to remove the
tricarballylic acid side chains from fumonisins.31
The present work was designed to evaluate the eﬃcacy of a
feed additive to simultaneously reduce the adverse eﬀects of
DON and FB in pigs. The feed additive (FA) consisted of a
combination of both Eubacterium BBSH 797 and fumonisin
esterase FumD, targeting speciﬁcally DON and FB, respectively.
The eﬀect of FA was especially investigated on blood
hematology/biochemistry, histopathological observations
(liver, lung, small intestine), and immune response.
■ MATERIALS AND METHODS
Piglets, Housing, Diets, and Experimental Settings. Forty-eight
4-wk-old weaned castrated male pigs (Pietrain X Duroc X Large-white)
were obtained locally, acclimatized for 1 week, individually weighed, and
randomly allocated into 8 experimental groups at the animal facility of
the INRA ToxAlim Laboratory (France, Toulouse). For 35 days, pigs
were kept in batch pens, had ad libitum access to water, and were oﬀered
eight dietary treatments: (1) control diet, (2) control diet supplemented
with FA, (3) DON diet, (4) DON diet supplemented with FA, (5) FB
diet, (6) FB diet supplemented with FA, (7) DON + FB diet, (8) DON
+ FB diet supplemented with FA. Concentrations of mycotoxins in
diﬀerent diets are reported in Table 1. Nutrient concentrations met or
exceeded minimum requirements for piglets as previously described.18
The formulation of the four diets without feed additive FA has been
previously described in two papers.18,19 The formulation of the four
other diets with FA was prepared at the same time using the same
sources of FB and DON. In short, two strains of Fusarium, F.
graminearum, and F. verticillioides were used to produce DON and FB,
respectively. These strains were grown separately on rice. The FB
containing culture material was directly used to contaminate the basal
feed, whereas DON was puriﬁed prior to its addition to feed by
extracting the culture material with ethyl acetate and drying on silica gel
60 (Merck, Darmstadt, Germany). Homogenousmixing of the feed with
mycotoxins led to the eight diﬀerent treatments, and to similar inclusion
and consistent concentrations of DON and FB between treatments
(Table 1). FA in these diets consisted of a combination of bacteria and
recombinant bacterial enzyme [FA, Eubacterium BBSH 797 and
fumonisin esterase FumD (FUMzyme, EC 3.1.1.87); BIOMIN Holding
GmbH]. Regarding inclusion of FA, freeze-dried Eubacterium BBSH797
strain (6.25 × 108 CFU/kg of feed) was simultaneously incorporated
with raw materials and/or mycotoxins during feed processing. With
respect to the fumonisin esterase FumD, the enzyme was produced by
fermentation of recombinant Pichia pastoris as described before,31
except that expression of the fumD gene was driven by the GAP
promoter rather than the AOX1 promoter, and the cells were cultured in
a lab-scale fermenter. Culture supernatant containing FumD was freeze-
dried for storage and shipping. The freeze-dried enzyme preparation was
dissolved in water (26.4 g/L) and directly sprayed on a monolayer thin
of ﬁnished feed (10 mL/kg of ﬁnished feed equivalent to 0.264 g/kg or
100 U/kg, where one unit is the enzymatic activity that releases 1 μmol
tricarballylic acid per minute from 100 μM FB1 in 20 mM Tris-Cl buﬀer
pH 8.0 with 0.1 mg/mL BSA at 30 °C). Enzyme spraying was applied at
the animal facility just prior to giving feed to piglets. The measured
FumD activity per kg ﬁnished feed, determined as described in the unit
deﬁnition above, was 40 U.
The experimental design used in this study was randomized with six
repetitions (each animal represented one repetition). To evaluate the
vaccinal response, an immunization protocol was performed with
subcutaneous injections of ovalbumin (OVA) to all piglets. A ﬁrst
injection of 1 mg OVA was done at day 4 of the experiment, followed by
a second one of 2 mg OVA at day 16. Both inoculations consisted of
OVA dissolved in sterile PBS and mixed with incomplete Freund’s
adjuvant (Sigma, St-Quentin Fallavier, France). After 35 days of dietary
exposure, blood was collected in EDTA or heparin tubes from the left
jugular vein of piglets, for blood and plasma analysis. The next day pigs
were euthanized by electrical stunning followed by exsanguination.
Samples of lungs and liver were collected from all groups and ﬁxed in
10% buﬀered formalin for histopathological analysis. A portion of spleen
was ﬂash-frozen in liquid nitrogen and stored at −80 °C until processed
for measurements of cytokine mRNA. In addition, the small intestine
from all animals was removed, aligned, andmeasured on a table. A 15-cm
tissue segment was collected in the middle of the small intestine
corresponding to mid-jejunum, divided in two subsamples, and stored
either in formalin or at −80 °C for the analysis of histopathology or
cytokine mRNA levels, respectively.
All animal experimentation procedures were carried out in
accordance with the European Guidelines for the Care and Use of
Animals for Research Purposes (Directive 86/609/EEC). Two of the
authors have an oﬃcial agreement from the French Veterinary Services
for animal experimentation.
Hematology, Biochemistry, Sa/So Ratio. The total white blood
cell population and the neutrophils subpopulation were counted as
already reported.18 Similarly, plasma concentrations of creatinine and
albumin were determined as described in our previous study.18
Table 1. AnalyzedMycotoxin Concentrations of Experimental
Dietsa
concentrations of mycotoxins in the diets (in μg/kg feed)
formulated diet deoxynivalenol fumonisin B1 fumonisin B2
Without Feed Additive (FA−)
control 539 <LOD <LOD
DON 2847 <LOD <LOD
FB 421 4113 1799
DON + FB 3091 4512 2025
With Feed Additive (FA+)
control 500 <LOD <LOD
DON 2953 <LOD <LOD
FB 476 4856 2180
DON + FB 2707 4090 1843
aLOD = limit of detection corresponding to 25 μg/kg for both
fumonisin B1 and B2. In addition, deoxynivalenol, zearalenone, and
enniatin were found to be naturally present in the cereals used,
resulting in concentrations of 500, 50, and 100 μg/kg of feed,
respectively. All other mycotoxins, including aﬂatoxins, T-2 toxin, HT-
2 toxin, and ochratoxin A, were below the limit of detection.
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The concentrations of the sphingoid bases sphinganine (Sa) and
sphingosine (So) were determined in plasma samples collected at the
end of the trial. In addition, the Sa/So ratio was calculated for each
animal. Sample preparation and HPLC-FLD analysis were carried out as
previously described.30
Histopathology of Hepatic, Pulmonary, and Intestinal
Tissues: Lesions and Cell Proliferation. The diﬀerent tissues
collected at slaughter and stored in formalin were then dehydrated
through graded alcohols and embedded in paraﬃn wax. Classic staining
of 3-μm sections by hematoxylin/eosin (HE) allowed us to record
several types of lesions depending on the tissue studied. The recorded
lesions were characterized according to their severity and their extent,
leading to the establishment of a lesion score per animal. Published
methods were used to calculate the lesion score in liver and lung,18 and
in jejunum.19 For each tissue, the minimal scores were 0, and the
maximal scores were 21, 33, and 38 for liver, lung, and jejunum,
respectively.
The cellular proliferation was assessed by counting Ki-67-positive
nuclei on formalin-ﬁxed embedded liver sections as already described.18
The number of Ki-67-positive nuclei among the total of 100 nuclei was
counted on the sections under light microscopy at 40× magniﬁcation.
The proliferative index was calculated by Ki-67-positive cells/total cells
× 100. In the jejunum, epithelial cell proliferation was estimated by
counting the number of mitosis ﬁgures in the enterocytes in ten random
ﬁelds on hematoxylin/eosin-stained slides using 40× magniﬁcation.
Determination of the Immune Responses: Lymphocyte
Proliferation, Antibody Synthesis, Cytokine Expression. Blood
samples obtained at day 35 were subdivided and used either for blood
culture or for plasma harvest. To evaluate the lymphocyte proliferation
upon antigenic stimulation, total blood was initially incubated for 48 h in
culture medium supplemented with the OVA antigen, and then for a
further 24 h period with medium supplemented by [3H]-thymidine. As
previously reported,10 incorporation of thymidine was measured with a
liquid scintillation beta counter (Kontron Instruments, St. Quentin en
Yvelines, France), and results were expressed as counts per minute in
stimulated culture/cpm in control nonstimulated culture.
In addition to the analysis of the speciﬁc cellular response, the
humoral response developed following immunization was evaluated
through the measurement of anti-OVA immunoglobulins in plasma. As
already described,18 titers of speciﬁc anti-OVA antibodies were
determined by ELISA, and two subsets of immunoglobulins, IgG and
IgA, were investigated.
To complete the immune analysis, the proﬁle of cytokine expression
was investigated in spleen which is considered as a peripheral lymphoid
organ. The diﬀerent steps and conditions required to the expression
analysis, namely tissue RNA processing, quality, and concentrations of
extracted RNA, cDNA production, and real-time PCR, were performed
as previously described.18 The sequence of the primers used is detailed
in Table 2. Ampliﬁcation eﬃciency and initial ﬂuorescence were
determined by DART-PCR method.32 Then, values obtained were
normalized by both house-keeping genes beta2-μglobulin and ribosomal
protein L32 (RPL32). Finally, gene expression was expressed relative to
the control group without FA. Likewise, the same procedure was applied
on the jejunum to examine the levels of these immune mediators after
mycotoxin and/or feed additive ingestion.
Statistical Analysis. Following the Fisher test on equality of
variances, one way ANOVA using Statview software 5.0 (SAS Institute,
Cary, NC) was used to analyze the diﬀerences between the diﬀerent
treatment groups of animals at each time point. P values of 0.05 were
considered signiﬁcant.
■ RESULTS
Evaluation of FB, DONwith and without Feed Additive
on the Hematological/Biochemical Parameters. Analysis
of blood at the end of the trial revealed that ingestion of themono
FB- and co-contaminated diets reduced the proportion of
neutrophils (relative to the total white blood cells, Table 3,
control without FA versus FB and DON + FB without FA, p =
0.018 and 0.046, respectively). In both of these diets, addition of
FA signiﬁcantly restored the neutrophil count, showing similar
values to the control groups (Table 3, FB without FA versus FB
with FA, p = 0.025, andDON+FBwithout FA versus DON+FB
with FA, p = 0.013).
Analysis of some biochemical analytes at the end of the trial
showed minor eﬀects, such as a decreased albumin concentration
in DON without FA group and an increased creatinine
Table 2. Nucleotide Sequence of Primers for Real-Time PCR
gene primer sequence Genbank no. ref
RPL32 F (300 nM) TGCTCTCAGACCCCTTGTGAAG R (300 nM) TTTCCGCCAGTTCCGCTTA NM_001001636 4
β2-μglobulin F (900 nM) TTCTACCTTCTGGTCCACACTGA R (300 nM) TCATCCAACCCAGATGCA NM_213978 9
IL-12p40 F (300 nM) GGTTTCAGACCCGACGAACTCT R (900 nM) CATATGGCCACAATGGGAGATG NM_214013 9
IL-8 F (300 nM) GCTCTCTGTGAGGCTGCAGTTC R (900 nM) AAGGTGTGGAATGCGTATTTATGC NM_213867 18
IL-1β F (300 nM) GAGCTGAAGGCTCTCCACCTC R (300 nM) ATCGCTGTCATCTCCTTGCAC NM_001005149 9
IL-6 F (300 nM) GGCAAAAGGGAAAGAATCCAG R (300 nM) CGTTCTGTGACTGCAGCTTATCC NM_214399 18
IFN-γ F (300 nM) TGGTAGCTCTGGGAAACTGAATG R (300 nM) GGCTTTGCGCTGGATCTG NM_213948 46
TNF-α F (300 nM) ACTGCACTTCGAGGTTATCGG R (300 nM) GGCGACGGGCTTATCTGA NM_214022 40
Table 3. Eﬀects of Mycotoxin-Contaminated Diets with or without Feed Additive (FA) on Hematology and Biochemistry
Parameters at Day 35 Post-Exposurea
hematology biochemistry
diet neutrophils proportion of WBC (in %) creatinine (μmol/L) albumin (g/L) Sa/So ratio
control 34.4 ± 3.9a 102.5 ± 5.3a 34.3 ± 0.7a 0.20 ± 0.01a,b
control with FA 33.8 ± 3.2a 101.7 ± 3.7a 34.6 ± 1.1a 0.23 ± 0.02a,b
DON 35.1 ± 1.8a 98.0 ± 4.1a 29.2 ± 1.5b 0.22 ± 0.02a,b
DON with FA 33.3 ± 3.3a 96.5 ± 6.9a 33.4 ± 2.1a,b 0.20 ± 0.02a,b
FB 21.7 ± 2.3b 120.5 ± 5.6b 35.1 ± 2.1a 1.04 ± 0.09c
FB with FA 36.4 ± 4.9a 100.0 ± 3.1a 35.3 ± 2.8a,b 0.18 ± 0.01a
DON + FB 25.0 ± 1.4b 101.6 ± 5.5a 32.8 ± 2.1a,b 0.92 ± 0.06c
DON + FB with FA 37.8 ± 4.0a 101.6 ± 5.1a 30.2 ± 1.0b 0.24 ± 0.02b
aResults are expressed for 6 animals ± SEM for hematology and Sa/So ratio, and for 5 animals ± SEM for creatinine and albumin. Means within a
column with no common letter are signiﬁcantly diﬀerent (P < 0.05). Sa, sphinganine; So, sphingosine; WBC, white blood cells.
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concentration in FB without FA group. Addition of FA in these
diets prevented the aforementioned changes in piglets (Table 3,
DON without FA versus DON with FA, p = 0.141 for albumin;
FB without FA versus FB with FA, p = 0.012 for creatinine).
As expected, at day 35 both mono- and co-contaminated diets
containing FB led to a signiﬁcant increase of the sphinganine
(Sa)/sphingosine (So) ratio in plasma (4.5−5.2-fold increase
when compared to control group, p < 0.001). Conversely, this
marked elevation of Sa/So was no longer observed in animals fed
these diets supplemented with FA (Table 3, FB without FA
versus FB with FA, p < 0.001; DON + FB without FA versus
DON + FB with FA, p < 0.001). Ingestion of DON had no
inﬂuence on this ratio.
Evaluation of FB, DONwith and without Feed Additive
on the Microscopic Lesions in Pulmonary and Hepatic
Tissues. Lesions recorded in the diﬀerent organs, lungs, liver,
and jejunumwere considered as mild to moderate for animals fed
any of the diets.
Fumonisins are well-known to induce pulmonary edema at
high doses (within 4−7 days when fed >90 mg FB/kg of feed) in
pigs.33 In the present experiment, FB present at low doses (6 mg
FB/kg of feed) in either mono- and co-contaminated diets
induced lesions in lungs, especially depletion of bronchiole-
associated lymphoid tissue and vascular disorders. As exempliﬁed
in Figure 1, these microscopic alterations resulted in a higher
score in comparison to the control group. Occurrence and extent
of these lesions were strongly diminished after addition of FA
(Figure 1, lesion score observed in FB and DON + FB diets
without FA: 6.6± 1.7 and 7.4± 1.2, respectively, versus 0.7± 0.7
and 2.8± 0.7 for FB and DON+ FB diets with FA, respectively, p
= 0.007 and p = 0.01, respectively).
The lesions recorded in the liver were mostly disorganization
of hepatic cords, cytoplasmatic and nuclear vacuolization of
hepatocytes, and megalocytosis. Combination of DON and FB
resulted in higher occurrence and extent of these lesions, as
shown by lesion scores in Figure 1. Addition of FA revealed a
partial recovery in the mono-FB contaminated diet (38% less). In
the other contaminated diets lesion scores were not diﬀerent
from those without FA. Surprisingly, the lesion scores in both
control groups were signiﬁcantly diﬀerent (Figure 1). Although
much less pronounced than for the contaminated diets, a few
lesions (megalocytosis and disorganization of hepatic cords)
were recorded in hepatocytes of animals from the control group
with FA.
Additionally, FA showed a beneﬁcial eﬀect on proliferation of
hepatocytes. The marked increase of hepatocyte proliferation
induced by the co-contamination of toxins was no longer
observed when FA was added in this diet (mean proliferation
indexes: 19.0 ± 0.9 versus 39.4 ± 12.8, p = 0.002, for DON + FB
with and without FA, respectively).
Evaluation of FB, DONwith and without Feed Additive
on the Intestinal Disorders. Like for liver and lung, the same
method was applied to score the intestinal morphology. In the
jejunum of animals fed the contaminated diets without FA, the
histopathological analysis revealed the occurrence of many
lesions, mostly villi ﬂattening and fusion, and lymphatic vessels
dilation.19 Inclusion of FA in these diets markedly decreased the
occurrence and extent of lesions (Table 4). Although a few
animals fed contaminated diets with FA exhibited interstitial
edema in the lamina propria, the occurrence of villi ﬂattening and
fusion as well as cytoplasmatic vacuolation and necrosis almost
disappeared, especially in animals from the DON andDON+ FB
groups. In these groups, lesion scores were not signiﬁcantly
diﬀerent from the ones of control groups (Table 4), and account
for the overall signiﬁcant positive eﬀect of FA in comparison to
diets without FA (p = 0.02).
Similarly in the jejunum, the enterocyte proliferation assessed
through the number of mitosis was totally restored when FA was
added in the contaminated diets (Table 4). A reduction of
Figure 1. Eﬀect of a 35 day exposure to mycotoxin-contaminated diets with and without feed additive (FA) on the lung and liver histology. Pigs received
four diﬀerent diets (control, DON, FB, DON + FB) without FA (dark gray) or the same four diets with FA (light gray). (A) BALT depletion and (B)
alveolar edema. HE 40×. (C) Hepatocyte megalocytosis (arrow) and (D) hepatocyte cytoplasmatic vacuolization. HE 40×. Lesion scores were
established after histological examination according to the severity and the extent of the lesions. Values are mean ± SEM for ﬁve animals: *, p value
<0.05; **, p value <0.01; ***, p value <0.001.
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enterocyte proliferation in the presence of FA was also observed
in the control group (p = 0.04, Table 4).
At the end of the trial, transcriptomic analysis was also
performed in jejunal samples to investigate the expression of four
pro-inﬂammatory cytokines, IL-1β, IL-6, IFN-γ, and TNF-α. A
signiﬁcant upregulation of cytokines was observed in the small
intestine of piglets fed the contaminated diets. This increase was
partially or totally abolished in the animals receiving diets
supplemented with FA (Figure 2). The statistical analysis
between all diets without FA and with FA resulted in a p value
<0.05, except for IL-6 mRNA which only showed an eﬀect
following DON consumption. The FA added to mono-DON-
contaminated diet reduced the expression of IL-1β and IL-6 by
34% and 43%, respectively (Figure 2). Similarly, a reduction of
34% and 32% on the mRNA levels encoding for IFN-γ and TNF-
α, respectively, was observed in themono-FB-contaminated diets
with FA. When both DON and FB were co-contaminated in the
diet, the inclusion of FA reduced the expression of IFN-γ and
TNF-α by 31% and 39%, respectively (Figure 2).
Evaluation of FB, DONwith and without Feed Additive
on Speciﬁc Immune Response. After 35 days of exposure to
mycotoxins, the vaccinal response to OVA was assessed in
animals receiving the diﬀerent diets with or without FA.
Lymphocyte proliferation was evaluated following the in vitro
stimulation of blood lymphocytes with OVA. Vaccination of
animals with OVA must have resulted in activation of speciﬁc
lymphocytes in secondary lymphoid tissue, through priming with
OVA-presenting cells. Ingestion of DON and FB, alone or in
combination, resulted in low indexes of proliferation (close to 1),
suggesting that lymphocytes from these animals were unable to
proliferate upon antigenic stimulation (Table 5). The ability of
lymphocytes to proliferate was increased by 1.9-, 1.5-, and 2.2-
fold when FA was added into the DON, FB, and DON + FB
diets, respectively (Table 5). Because of the high individual
variability, the increase between diets supplemented or not with
FA was only signiﬁcant in the case of the DON + FB1
contaminated diets.
Table 4. Eﬀects of Mycotoxin-Contaminated Diets with or
without Feed Additive (FA) on the Lesion Score and on the
Enterocyte Proliferation in the Jejunum at Day 35 Post-
Exposurea
lesion scoreb no. of mitosic cells
control 0.67 ± 0.33a 2.37 ± 0.36a,e
control with FA 0.83 ± 0.40a 1.41 ± 0.18c
DON 6.17 ± 1.72b 1.73 ± 0.26b
DON with FA 2.50 ± 1.02a,b 2.18 ± 0.28a,d
FB 4.17 ± 1.14b,c 1.67 ± 0.21b,c
FB with FA 3.17 ± 0.95b,c 2.35 ± 0.26a,e
DON + FB 6.17 ± 2.02b,c 1.91 ± 0.19b,d
DON + FB with FA 2.00 ± 0.68a,c 2.72 ± 0.19e
aResults are expressed for 6 animals ± SEM. Means within a column
with no common letter are signiﬁcantly diﬀerent (P < 0.05).
Enterocyte proliferation is the mean number of mitosic cells per
microscopic ﬁeld. For the graphic: A indicates ﬂattening of villous tips
and B indicates lymphatic vessel dilation. HE 10×. bLesion scores were
established after histological examination according to the severity and
the extent of the lesions.
Figure 2. Eﬀect of a 35 day exposure to mycotoxin-contaminated diets with and without feed additive (FA) on the cytokine expression in jejunum at day
35 postexposure. Pigs received four diﬀerent diets (control, DON, FB, DON + FB) without FA (dark gray) or the same four diets with FA (light gray).
Quantiﬁcation of the relative cytokine mRNA level for each sample is expressed in arbitrary units (AU). Values are mean ± SEM for ﬁve animals: *, p
value <0.05; **, p value <0.01; ***, p value <0.001.
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Two classes of antibodies, IgG and IgA, recognizing
speciﬁcally OVA were assessed in plasma at the end of the
trial. The level of anti-OVA IgG was aﬀected by mycotoxin
consumption, the stronger eﬀect being observed when
mycotoxins were combined (Table 5). Inclusion of FA in the
DON + FB diet allowed 33% recovery of the anti-OVA IgG level.
Regarding anti-OVA IgA, only the diet mono-contaminated with
DON diet aﬀected the plasma concentration of this isotype.
Inclusion of FA in this DON-contaminated diet partially restored
the anti-OVA IgA level (Table 5).
Expression of several cytokines was determined in the spleen
following the euthanasia of animals. Overall, ingestion of
contaminated diets resulted in a reduced expression of IL-6,
IL-1β, IL-12p40, and IL-8. The eﬀect was more pronounced in
the diet contaminated with both DON and FB (Figure 3). When
the diets were supplemented with FA, the proﬁle of mRNA levels
encoding IL-6, IL-1β, IL-12p40, and IL-8 was restored, and the
cytokine expression levels were similar to the ones observed in
the control group (Figure 3). The greater recoveries were
noticed in the co-contaminated diet ranging from 51% to 107%.
■ DISCUSSION
The aim of the present work was to investigate the eﬃcacy of FA
to prevent the toxic eﬀects of two fusariotoxins, DON and FB. So
far, mycotoxin decontamination/detoxiﬁcation has mainly been
studied in the context of the exposure to a single mycotoxin.
However, most fungi are able to produce several mycotoxins
simultaneously, and it is a common practice to use multiple grain
sources in animal diets.15 As a consequence, animals are
commonly exposed to more than one mycotoxin. In this respect,
the eﬃcacy of a decontamination procedure or a feed additive is
also based on its ability to target several mycotoxins at the same
time, and subsequently to overcome the toxicity caused by
multitoxin contaminated feed. This is a real challenge
considering the diverse structure of mycotoxins. To this end,
the use of a blend of microorganisms or puriﬁed enzymes in a
feed additive is an interesting approach.
We previously reported the eﬀects of diets mono- and co-
contaminated with DON and FB.18,19 Among mycotoxins, these
two toxins from Fusarium species are of major concern
worldwide in terms of occurrence, as well as impact on animal
health and production. We showed that subclinical doses of
Table 5. Eﬀects of Mycotoxin-Contaminated Diets with or
without Feed Additive (FA) on Speciﬁc Immune Parameters
at Day 35 Post-Exposurea
immunoglobulins subsets
lymphocyte proliferation
index (ova stimulation)
IgG anti-OVA
(AU)
IgA anti-OVA
(AU)
control 3.79 ± 0.83a 1545 ± 113a 20.6 ± 2.5a
control with
FA
2.78 ± 0.45a 1387 ± 86a 22.1 ± 2.3a
DON 1.53 ± 0.32b,c 1333 ± 108a,b 33.1 ± 2.8b
DON with
FA
2.94 ± 0.97a,b 1464 ± 80a 25.4 ± 3.0a,b
FB 1.25 ± 0.10b 1101 ± 75b,c 21.5 ± 0.6a
FB with FA 1.89 ± 0.44a,b 1166 ± 138a,c 22.8 ± 3.8a
DON + FB 1.32 ± 0.27b 789 ± 210c 22.5 ± 2.2a
DON + FB
with FA
2.85 ± 0.64a,c 1052 ± 84b,c 22.6 ± 2.3a
aResults are expressed for 5 animals ± SEM. Means within a column
with no common letter are signiﬁcantly diﬀerent (P < 0.05). Ig,
immunoglobulin; OVA, ovalbumin.
Figure 3. Eﬀect of a 35 day exposure to mycotoxin-contaminated diets with and without feed additive (FA) on the cytokine expression in spleen. Pigs
received four diﬀerent diets (control, DON, FB, DON + FB) without FA (dark gray) or the same four diets with FA (light gray). Quantiﬁcation of the
relative cytokine mRNA level for each sample is expressed in arbitrary units (AU). Values are mean± SEM for ﬁve animals: *, p value <0.05; **, p value
<0.01; ***, p value <0.001.
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DON and FB aﬀect several key functions, ranging from a reduced
vaccination eﬃcacy, and an increased occurrence of lesions in
many tissues, to a chronic inﬂammatory disorder. Depending on
the end point assessed, the association of DON and FB led to
diﬀerent types of interaction. However, the ingestion of the co-
contaminated diet always led to greater toxicity than the mono-
contaminated diets. It was thus of interest to conduct the present
experiment and to determine the ability of a FA to neutralize the
eﬀect of the co-contaminated diet.
The FA incorporated in the feed was a combination of two
biological systems, bacteria and recombinant bacterial enzyme.
Many reports showed that the live bacterium used, Eubacterium
BBSH797, is able to convert DON into DOM-1, a metabolite
much less toxic.27,28 In the past, some in vivo trials also showed
beneﬁcial eﬀects of this bacterium when added in contaminated
feed with DON or other trichothecenes.34−36 With regard to the
Eubacterium itself, no concerns were noted in tolerance studies
(with piglets and chickens) in which the additive was supplied at
10-fold dose.37 The bacterial enzyme consists of fumonisin
esterase FumD, which is able to degrade FB into hydrolyzed
FB.31 Recently, this metabolite (HFB1) resulting from an initial
treatment with the enzyme did not cause any toxicity when given
orally to piglets.30 This work was in agreement with conclusions
of previous studies using pure HFB1.
38 With regard to inclusion
of the FA in the diets, the freeze-dried microorganism BBSH 797
was incorporated during feed milling at 0.25%. Fumonisin
esterase FumD was incorporated into feed through the enzyme
spraying on a monolayer of grains. This was a practical way of
application for experimental purpose, and clearly would not be
reﬂective of a suitable approach for commercial application.
Although the results of the experiment suggested that FumDwas
active in the porcine gastrointestinal tract, in a technological
application it might be possible to use a lower FumD dose if the
enzyme is provided with protective coating. Accordingly, further
work on the dietary supplementation of this enzyme needs to be
done. It must be mentioned that samples for mycotoxin analysis
were taken before and after enzyme spray application, and the FB
concentration of feed prior to feeding the pigs was found not to
be reduced.
In the present experiment, the low dose of mycotoxins used
did not cause feed refusal and did not interfere with animal
growth.18,19 Similarly, the incorporation of FA in the feed did not
aﬀect the growth of animals (data not shown). The minor
changes induced by mycotoxins on hematological and
biochemical parameters were overcome by the addition of FA.
This beneﬁcial eﬀect of FAwas already reported on the decreased
albumin concentration after DON and ZEA exposure.39 FA was
able to totally counteract the increase of Sa/So ratio induced by
FB. Indeed, ingestion of FB disrupts sphingolipid metabolism by
inhibiting ceramide synthase, leading to an increased Sa/So ratio
in plasma and tissues.30,38
The lung is a speciﬁc target of FB in swine,33 and although less
studied, ingestion of low doses of toxin induced pulmonary
lesions.7,18 In the present experiment, addition of FA showed a
beneﬁcial eﬀect, most likely through the action of the fumonisin
esterase FumD as the histopathological alterations induced by
FB were no longer noted in piglets fed the FB and DON + FB
diets supplemented with FA. As a target organ for many
mycotoxins, the liver was also aﬀected in the experiment. The
combination of both DON and FB caused hepatic lesions greater
than the ones observed with the individual toxins. This eﬀect was
slightly reversed after ingestion of this diet with FA. Addition of
FA provided a partial protection against the induction of hepatic
lesions in the mono-FB contaminated diet. Lesion scores for
both control groups (with and without FA) diﬀer signiﬁcantly;
however, the score in the group containing FA was relatively low
(score = 2) and in the same range of the one obtained in the
control group of another separate experiment.30 In line with that,
the FA had no eﬀect on the index of hepatocyte proliferation, and
helped to counteract the eﬀect observed in the co-contaminated
diet.
As previously reported, activation of the immune system is
needed to observe the eﬀects of low doses of mycotoxins.10,18,40
Immunization of animals leads to the development of a speciﬁc
response, involving the recruitment, activation, and proliferation
of immune competent cells. Most mycotoxins alter protein
synthesis, and therefore make dividing and activated cells, such as
immune cells, speciﬁc targets. In line with that, the literature is
rich with examples of how mycotoxins compromise immune
functions, such as depressed T- or B-lymphocyte activity,
suppressed antibody production, and impaired macrophage/
neutrophil−eﬀector functions.2 As a consequence, this immu-
nomodulation may eventually decrease resistance to infectious
diseases, reactivate chronic infections, and/or decrease vaccine
and drug eﬃcacy.2 In the present experiment we observed that
the mono- and co-contaminated diets induced a reduced
expression of several cytokines. Addition of FA was able to
restore the expression of mRNA levels encoding for IL-8, IL-6,
IL-1β, and IL-12p40 to the level observed in control animals.
These data might account for the eﬀects observed in the in vitro
proliferation of lymphocytes. Indeed, the speciﬁc lymphocytes
generated in secondary lymphoid organs were unable to
proliferate upon OVA stimulation, whereas those from piglets
fed the contaminated diets with FA showed a better ability to
respond to the same stimulation. It might be suggested that,
within the spleen, the interaction and subsequent activation
between antigen-presenting cells and T-lymphocytes did not fail
as much as in animals fed the contaminated diets without FA. As
a consequence, these animals showed reduced concentrations of
speciﬁc anti-OVA IgG in their plasma, most notably those fed FB
and DON + FB diets. However, the FA added in these respective
diets was not able to totally restore the concentrations of this
speciﬁc immunoglobulin isotype. The improvement was mainly
observed when both DON and FB were present. Very recently,
the ameliorative eﬀect of a similar FA on antibody titers was
reported in case of intoxication of broiler chicks with 10 mg
DON/kg of feed.41
Beyond the toxicity on the immune response, DON and FB
are known to aﬀect the gut epithelium of piglets.6,42,43 The
gastrointestinal tract is the ﬁrst organ coming into contact with
mycotoxins of dietary origin and should be expected to be
aﬀected by mycotoxins with greater potency as compared to
other organs. This aspect is often a neglected area on mycotoxin
research, although the nonabsorbed part of mycotoxins
remaining in the intestine and their dynamic within the
gastrointestinal tract strongly suggest that these metabolites are
able to compromise key functions of the intestine.6 In this
respect, the FAmust be rapidly released from the stomach and be
active for an immediate action in the intestine of animals. A few
intestinal parameters were then investigated to evaluate how FA
acts in the small intestine and could prevent the intestinal toxicity
of DON and FB. Histopathological observations in the jejunum
showed that substantially fewer microscopical lesions were
recorded in animals fed the contaminated diets with FA,
especially the DON and DON + FB diets. Furthermore, the
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restoration observed in enterocyte proliferation might explain
why animals fed with FA did not exhibit villi ﬂattening.
The chronic ingestion of low doses of mycotoxins might result
in persistent inﬂammatory condition in the intestine.44 Among
alterations reported, the upregulation of pro-inﬂammatory
cytokines all along the small intestine is one of the prominent
features. In the present experiment, mRNA levels of IL-1β, IL-6,
TNF-α, and IFN-γ were found upregulated in jejunum of piglets
fed either the mono- or co-contaminated diets. Conversely,
addition of FA in these diets allowed the gut epithelium
maintaining the cytokine response. Interestingly, IL-6, a cytokine
known to drive the synthesis of IgA which is mostly found in the
mucosal area, was not upregulated after inclusion of FA in the
DON-contaminated diet. This ﬁnding may account for the
reduced elevation of IgA-induced DON in the plasma of animals
fed the DON diet with FA. As widely reported, the DON eﬀect
on IgA can lead to the accumulation of this immunoglobulin
isotype in the kidney, such as what has been observed in IgA
nephropathy.45 In the present experiment, the expression of tight
junctions (TJ) was not analyzed as was previously reported in the
intestine of pig exposed to DON or FB.19,43 However,
considering the regulation of TJ by pro-inﬂammatory cytokines,
we can anticipate that FA prevents the alteration of the
expression of TJ induced by mycotoxins.
In conclusion, the results presented herein demonstrate that a
FA combining two speciﬁc biotransformation processes is able to
partially to totally neutralize the toxic eﬀects induced by DON
and FB, two structurally diﬀerent mycotoxins from Fusarium.
Inclusion of FA could allow animals to develop an appropriate
immune response following an antigenic challenge. Vaccination
and pathogenic challenges are two common situations
encountered in animal husbandry, and FA may help the animal
to face mycotoxin-induced impairment of the immune response.
Inclusion of FA in contaminated feeds may also reduce intestinal
disorders (inﬂammation and malabsorption) due to mycotoxins.
More importantly, animals are usually exposed to several
mycotoxins at the same time,13−15 and therefore the data
presented here indicate that combination of speciﬁc biotrans-
forming enzymes may counteract the toxic eﬀects induced by the
coexposure to diﬀerent mycotoxins.
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